-

Welcome to “Wita”: Claritin® Aims to Take the ‘Itch’ Out of Wichita, the #1 Allergy Capital in the U.S., Just in Time for Fall Allergy Season

In connection with its introduction of Claritin® Liquid, Actress Natasha Rothwell, Who Was Born in Wichita, Calls on Locals to Sign a Petition to Rename City to ‘Wita’, Helping them Ditch the Allergy-Induced Itch

WHIPPANY, N.J.--(BUSINESS WIRE)--Itching for allergy relief this fall? So are residents of Wichita, Kansas, the No. 1 allergy capital in the United States, according to the Asthma and Allergy Foundation of America (AAFA). This September, Claritin®, the #1 doctor-recommended non-drowsy oral allergy OTC brand from Bayer, is aiming to take the “itch” out of Wichita and bring relief to its residents with its newest innovation, Claritin® Liquid. The new product is the only allergy treatment to offer the proven allergy relief of non-drowsy Claritin® in an instantly soothing Cooling Honey Flavored Liquid, providing 24-hour indoor and outdoor allergy relief of the most irritating allergy symptoms, including itchy throat.

Together with new spokesperson, who was born in Wichita and is no stranger to allergy symptoms, Natasha Rothwell, Claritin® is calling on Wichita residents to sign a petition to change the city’s name to “Wita” in celebration of its new product and its ability to help them ditch the itch. If the petition reaches 1,000 signatures, Claritin® and Rothwell will pop up in the city to give local allergy sufferers the chance to experience the powerful relief that Claritin® Liquid provides with 1,000 free product samples (while supplies last).

“I know how frustrating seasonal allergies can be,” said Natasha Rothwell, born in Wichita. “I am excited to come out and help end the itch.”

In addition to offering residents of Wichita free samples of its New Cooling Honey Flavored Liquid if the petition reaches 1,000 signatures, Claritin® has also committed a monetary donation to the Wichita Parks Foundation to give everyone the chance to enjoy the outdoors.

“Wichita is celebrated as the Air Capital of the World and offers so much to its residents from its vibrant downtown to its beautiful parks, but it’s also notorious for its higher-than-average tree and grass pollen,” said Trevor Thrun, Vice President and General Manager of Upper Respiratory at Bayer. “Claritin remains dedicated to helping allergy sufferers enjoy their lives, and we’re proud to support this commitment by contributing to the Wichita Parks Foundation. Our goal is for everyone to fully enjoy this beautiful city without the discomfort of itchy nose, throat and eyes.”

NEW Claritin® Liquid provides non-drowsy 24-hour relief from itchy throat or nose, sneezing, runny nose, and itchy, watery eyes that can be triggered by allergens such as pollen, dust mites, pet dander and mold. The product is available in 2.7 and 8.0 fluid-ounce bottles, which can be purchased online at Amazon.com and in-store at retailers nationwide including CVS, Kroger, Walgreens and Walmart. The MSRP ranges from $9.99 - $26.99 USD.

For more information about Claritin® Liquid, visit www.Claritin.com.

Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.us.

Bayer U.S. Social Media Channels: Facebook / X / Instagram

Bayer, the Bayer Cross, and Iberogast are trademarks of Bayer.

Contacts

Danielle K. Goonan
Senior Director, Strategic Communications, Brand PR, Social and Influencer
danielle.goonan@bayer.com

Bayer LogoBayer Logo

Bayer


Release Summary
Welcome to “Wita”: Claritin® Aims to Take the ‘Itch’ Out of Wichita, the #1 Allergy Capital in the U.S., Just in Time for Fall Allergy Season
Release Versions

Contacts

Danielle K. Goonan
Senior Director, Strategic Communications, Brand PR, Social and Influencer
danielle.goonan@bayer.com

More News From Bayer

Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that a broad set of data from its stroke franchise will be presented at the 2026 European Stroke Organisation Conference (ESOC), including new late-breaking analyses from its global, landmark Phase III OCEANIC-STROKE study of asundexian, an investigational oral Factor XIa inhibitor. In total, 13 abstracts will be presented, including four OCEANIC-STROKE sub-analyses. Additionally, Bayer will present nine real-world analyses examining stroke...

Post Durnell Argument Scenario Statements – Attributable to Monsanto

LEVERKUSEN, Germany & ST. LOUIS--(BUSINESS WIRE)--“We appreciate the Court’s careful consideration of FIFRA’s Uniformity language and how its federal preemption provision applies to state-based label warnings. “We believe the U.S. Government and the Company made persuasive arguments that state-based warning claims ‘in addition to or different from’ warning labels approved by EPA under FIFRA, as in Durnell, are preempted, and this is necessary to avoid a patchwork of 50 different warning labels....

Media Alert for Durnell Supreme Court Argument

LEVERKUSEN, Germany & ST. LOUIS--(BUSINESS WIRE)--On April 27th, Monsanto will argue before the U.S. Supreme Court in Durnell v. Monsanto, a Roundup case involving the application of federal preemption under FIFRA. A favorable ruling by the Supreme Court would provide essential regulatory clarity for companies who seek to bring currently approved and new products to market, addressing their ability to serve U.S. farmers and consumers. Former Solicitor General Paul Clement will argue the case fo...
Back to Newsroom